Skip to main content
Pain in PsA = predictor of disability and QoL

TYK-2 inhibition lowered clinical pain outcomes and ALSO pain-associated

Brian Jaros, MD Dr_Brian_MD

1 year 9 months ago
Pain in PsA = predictor of disability and QoL TYK-2 inhibition lowered clinical pain outcomes and ALSO pain-associated biomarkers vs PBO @RheumNow #ACR24 Abstract #2366 https://t.co/DAgmdmmTE0
Risk for atypical femoral fracture:

🚨Asian race - 4-6x higher risk
Duration of use is greater risk than older age

H

Eric Dein ericdeinmd

1 year 9 months ago
Risk for atypical femoral fracture: 🚨Asian race - 4-6x higher risk Duration of use is greater risk than older age Higher risk when given for osteoporosis than cancer treatment - Compare: osteonecrosis of jaw more common with cancer Rx #ACR24 Review Course @RheumNow https://t.co/V8cD5QWNGp
Weight Loss from Anti-Obesity Medications Prevents Gout

A population based study looked at the effect of the weight lo

Dr. John Cush RheumNow

1 year 9 months ago
Weight Loss from Anti-Obesity Medications Prevents Gout A population based study looked at the effect of the weight loss drug, Orlistat, in obese individuals. Compared to those untreated, orlistat over 1 year was associated with significant weight loss and significantly lower… https://t.co/P1iRjtHgHV https://t.co/MoohUKGvUn
Study of 237 SLE pts shows mood disorders, fibromyalgia & chronic damage were major determinants of poorer Quality o

Dr. John Cush RheumNow

1 year 9 months ago
Study of 237 SLE pts shows mood disorders, fibromyalgia & chronic damage were major determinants of poorer Quality of life in SLE. mean SLEDAI-2k was 1.7, 29% had FM; 44% had chronic damage. https://t.co/JHzmleVMIK https://t.co/Sqk9K6oA7M
Don’t use ‘biopsy-proven’ to label sarcoidosis; use ‘biopsy supported’ as there are many causes of granulomato

TheDaoIndex KDAO2011

1 year 9 months ago
Don’t use ‘biopsy-proven’ to label sarcoidosis; use ‘biopsy supported’ as there are many causes of granulomatous inflammation. It’s happened to one of my pts who was diagnosed with “biopsy-proven” sarcoidosis - she actually had CVID with GLILD. #ACRReview #ACR24 https://t.co/it41va1K6g
ACR 2024 starts tomorrow. Here are a few previews of abstracts to be presented, along with my recommendations of sessions you don’t want to miss.
Survey of 779 RA pts in the National Rheumatoid Arthritis Society. Respondents were 95% Caucasian in their 50s with meno

Dr. John Cush RheumNow

1 year 9 months ago
Survey of 779 RA pts in the National Rheumatoid Arthritis Society. Respondents were 95% Caucasian in their 50s with menopause in their 40s. 80% responded that their arthritis was worse during the menopause with 10% being much worse. https://t.co/NqZXK1lLQe https://t.co/k59HD5bKrd
PAs in rheumatology report higher job satisfaction and lower burnout rates compared to PAs. Study of 430 PAs practicing

Dr. John Cush RheumNow

1 year 9 months ago
PAs in rheumatology report higher job satisfaction and lower burnout rates compared to PAs. Study of 430 PAs practicing in rheumatology. median age = 39 yrs, 85% female. They are 79%office-based practices, more likely to Tx older pts & engage in telemedicine(62.5%)… https://t.co/Zti5YMBo8o https://t.co/2XaWjythR1
Dysregulated overproduction of angiopoietin-like protein 4 (ANGPTL4) may be involved in RA pathogenesis. Markedly elevat

Dr. John Cush RheumNow

1 year 9 months ago
Dysregulated overproduction of angiopoietin-like protein 4 (ANGPTL4) may be involved in RA pathogenesis. Markedly elevated in RA tissues & is a regulator of angiogenesis & inflammation. Anti-ANGPTL4 inhibited Dz in mice and fibroblast-like synoviocyte migration &… https://t.co/aOpnxicQSs https://t.co/1BC8CxwF6V
Biosimilar Slow Growth in USA

A recent Forbes article, "Biosimilars Are Making Inroads In U.S., But It’s Still A Bum

Dr. John Cush RheumNow

1 year 9 months ago
Biosimilar Slow Growth in USA A recent Forbes article, "Biosimilars Are Making Inroads In U.S., But It’s Still A Bumpy Ride", reviews the current state and reasons for slowish uptake of these significant cost-savings alternatives to biologic therapy in treating cancer and… https://t.co/yO3tUVk2jj https://t.co/ft6gqpnWMx
Early RA Journey - Patient Perspectives and Uncertainties

Canadian early RA (ERA) patients were interviewd to depict t

Dr. John Cush RheumNow

1 year 9 months ago
Early RA Journey - Patient Perspectives and Uncertainties Canadian early RA (ERA) patients were interviewd to depict their perspectives from onset and diagnosis to referral and care. This report highlights the importance of patient pain and primary care physician (PCP) intake… https://t.co/gwNL7iZIT5 https://t.co/SL0Jw0H8f6
How to Master ACR Meetings
×